Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Elara MD vs Ways2Well

Elara MD
Graded #467

Higher grade

vs+0.6000000000000014
Ways2Well
Graded #477

Lower grade

The verdict

Elara MD takes it — 53.5/100 to 52.9/100, but only just.

Elara MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Elara MD is a weight-loss and wellness telehealth platform offering weekly injectable GLP-1 therapy alongside a peptide menu (NAD+, sermorelin, glutathione). Ways2Well is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueWays2Well +5
40
45
Dose & formulationElara MD +14
54
40
Clinical oversightWays2Well +2
63
65
Labs & monitoringWays2Well +12
52
64
FulfillmentElara MD +11
66
55
Contract termsEven
55
55
Elara MD · left barWays2Well · right bar

The numbers

MetricElara MDWays2Well
WeighScore53.5/10052.9/100
GradeCC
Scorecard rank#467#477
Semaglutide$249/mo (0.2 mg dose, compounded)Not disclosed
Tirzepatide$349/mo (2.0 mg dose, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Elara MD

Graded #467 · C

Strengths

  • Dose-banded monthly pricing published on-site ($249–$649/mo across tiers)
  • Both a semaglutide-range and a tirzepatide-range (GLP-1/GIP) option, plus microdosing
  • Medication included in the monthly price with free fast shipping when prescribed
  • Broad reach claimed (over 40 states)

Where it loses points

  • Molecules not named on-site (only 'Personalized GLP-1') — compounded status is inferred
  • No FDA compounded-medication disclaimer published
  • No named compounding pharmacy partner — prescriptions are patient-directed
  • LegitScript certification, medical director, and full state list not disclosed
  • Pricier than several compounded competitors
Ways2Well

Graded #477 · C

Strengths

  • Lab-based, clinician-directed care with bloodwork and biomarker tracking
  • Compounded GLP-1 filled by its named sister pharmacy, ReviveRX
  • Established brand with a named founder (Brigham Buhler) and its own patient app

Where it loses points

  • GLP-1 weight-loss pricing is not published on the live site and is gated behind membership
  • State coverage is limited and not fully listed
  • Requires a membership and clinician protocol rather than a simple standalone GLP-1 plan

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard